Margrave David R. has filed 6 insider transactions across 1 company since June 2020.
Most recent transaction: a grant/award of 20000 shares of Lantern Pharma Inc. ($LTRN) on December 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 18, 2025 | Lantern Pharma Inc. | $LTRN | Margrave David R. | Chief Financial Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 11,184,423 | 9999.99% | 0.18% |
| June 15, 2020 | Lantern Pharma Inc. | $LTRN | Margrave David R. | Chief Financial Officer | D | Stock Option (Right to Buy) | 78300 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 15, 2020 | Lantern Pharma Inc. | $LTRN | Margrave David R. | Chief Financial Officer | A | Stock Option (Right to Buy) | 78300 | $0.00 | 78,300.0000 | 0 | 9999.99% | 0.00% |
| Oct. 29, 2021 | Lantern Pharma Inc. | $LTRN | Margrave David R. | Chief Financial Officer | D | Stock Option (Right to Buy) | 26100 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 29, 2021 | Lantern Pharma Inc. | $LTRN | Margrave David R. | Chief Financial Officer | A | Stock Option (Right to Buy) | 26100 | $0.00 | 26,100.0000 | 0 | 9999.99% | 0.00% |
| July 15, 2024 | Lantern Pharma Inc. | $LTRN | Margrave David R. | Chief Financial Officer | A | Stock Option (Right to Buy) | 52000 | $0.00 | 52,000.0000 | 0 | 9999.99% | 0.00% |